TriaCyte

Seed round

Worked with the founder throughout the seed round to build a coherent investment case.

CAR-T therapy has transformed treatment for some blood cancers. Solid tumors pose another challenge: reaching them, getting inside, and staying active. An AI-designed navigation system could help these therapies cross that barrier.